CoLucid Pharmaceuticals Inc.

(CLCD)

By |

Profile

CoLucid Pharmaceuticals Inc is a Phase 3 clinical-stage biopharmaceutical company that is developing a proprietary small molecule for the acute treatment of migraine headaches.

Contact Information

Website: www.colucid.com
Main Phone: +1 857 285-6495
Address: 222 Third Street
Address 2: Suite 1320
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02142

Issuer Information

Exchange: NSD
Employees: 7
NAICS: Pharmaceutical P
$ 40.35 $ 0.25 (0.62%)
Last Price 40.35 Change $ 0.25 Change % 0.62 Tick N/A
Bid 20.15 Bid Size 100.00 Ask N/A Ask Size 0.00
Open 40.00 High 40.80 Low 39.45 Prev Close 40.10
Last Trade Volume 170,853 52 Wk Hi 40.80 52 Wk Low 4.57
Market Cap 776.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 19,246,737.00 EPS (TTM) -3.25 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 20 29
Number of Buys 3 8
Number of Sells 17 21
Net Activity -150577 8323
Last 10 Buys Shares
Thomas P. Mathers 1,000
Arthur M. Pappas 1,000
Arthur M. Pappas 1,000
Luc Marengere 1,000
Last 10 Sell Shares
Raymond Skwierczynski 1,000
Raymond Skwierczynski 1,000
Thomas P. Mathers 1,000
Jesse I. Treu 1,000
Jesse I. Treu 1,000
Jesse I. Treu 1,000
Jesse I. Treu 1,000
Jesse I. Treu 1,000
Jesse I. Treu 1,000
Raymond Skwierczynski 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 22 22 22 23
Low Target Price Estimate 15 15 15 15
Mean Target Price Estimate 19.75 19.75 19.75 20.25
Standard Deviation 3.2 3.2 3.2 3.59
Date of Most Recent Estimate 08/10/16 08/10/16 05/12/16 08/22/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1